LeukemiaNet: A Transnational Model for Cooperative Leukemia Research.

6556 Background: Leukemia research may be jeopardized by lack of communication structures or fragmentation of study activities, insufficient interaction and underestimation of the problem. Methods: Recognizing that the only way to cure leukemia is by cooperative research, scientists in Europe in 2002, set out to establish an exemplary cooperative network for research in leukemia, the European LeukemiaNet (ELN). At present, ELN integrates 105 national leukemia trial groups and networks, 105 interdisciplinary specialty groups and about 1000 leukemia specialists from 175 institutions. They care for ten thousands of leukemia patients in 33 countries. Results: The most visible results are 1.) those due to the cooperative research projects and trials as reflected by a large number of high impact publications; and 2.) the guidelines and management recommendations for virtually every type of leukemia and interdisciplinary specialty which have lain the groundwork for uniform definitions and standards required for common clinical trials and projects. Conclusions: ELN is a model of transnational cooperation. Working together successfully has created a spirit of cooperation and mutual trust. Due to its structured and long-term cooperation, ELN is likely to have a durable impact on leukemia research in Europe. By promoting cooperation over competition that is necessary for good research, ELN provides a competitive advantage for all participants to the benefit of every patient with leukemia worldwide.